VRTX logo

Vertex Pharmaceuticals Incorporated

VRTX
0.00
USD
+0.00+0.00%

Vertex Pharmaceuticals Incorporated at a glance

Open VRTX on Vela

Vertex Pharmaceuticals Incorporated (VRTX) is a Healthcare company in the Biotechnology industry, headquartered in Boston, MA, with about 6,400 employees. Its shares trade on NASDAQ, and its IPO date is July 24, 1991. With a market capitalization of $126.6 billion, VRTX is a large-cap stock.

It trades an average of 1.4 million shares a day.

In its latest reported quarter (results released August 3, 2026), Vertex Pharmaceuticals Incorporated posted revenue of $3.3 billion and earnings of $4.73 per share, against estimates of $3.2 billion and $4.74.

Figures as of October 14, 2026, from market data providers. Descriptive only, not financial advice.

VRTX: Frequently asked questions

As of October 14, 2026, Vertex Pharmaceuticals Incorporated has a market capitalization of $126.6 billion, making it a large-cap company in the Healthcare sector.

Figures update throughout the day from market data providers. Nothing on this page is financial advice.